The antibody-based pharmaceuticals resource library’s Podcast

Development of Monoclonal Antibodies

In this episode, Creative Biolabs will introduce technologies of monoclonal antibody development, including hybridoma, surface display, B cell immortalization, and transgenetic technology. You will have a whole concept of mAb development after listening to the episode. 

De Novo Antibody Sequencing Service

What is de novo antibody sequencing? What are the steps of de novo antibody sequencing?  Are there any challenges in de novo antibody sequencing? How do we overcome these difficulties in antibody sequence analysis? Creative Biolabs will describe all these issues in the episode. 
 

Bacterial Display Technology

Bacterial display is a protein engineering technique widely used for in vitro protein evolution. In this episode, many aspects of bacterial display will be illustrated, such as cell surface display system in gram-positive/negative bacteria, components of bacterial display systems, construction and screening process of bacterial display library, and application of bacterial display.

Antibody Library Screening

As a new preparation technology for genetically engineered antibodies, antibody library technology has important theoretical and practical values in the cloning of human antibodies, antibody performance modification, and antibody gene research. Here, we will explore the de novo antibody library screening technologies and corresponding applications.

Antibody Humanization Service

What is antibody humanization? How to humanize an antibody? The definition and humanization process are illustrated by Creative Biolabs in this episode.

Antibody Diversity—Gene Rearrangement

In the episode, Creative Biolabs will detailed the mechanism of antibody diversity—gene rearrangement and antibody sequencing service. We hope this episode can help you understand the principle of complicated antibody diversity. 

100% Identification of Leucine and Isoleucine in De Novo Antibody Sequencing

This episode introduces the De Novo Antibody Sequencing service provided by Creative Biolabs, which can distinguish leucine from isoleucine with 100% accuracy. This valuable breakthrough improves functional analysis and verification and cost-effectively builds a strong foundation for downstream applications.

An Overview of Prostate Cancer

Prostate cancer is the most common cancer among men and predominately affects elderly men with a higher incidence. Deregulated production and secretion of growth factors by stromal cells within the PCa microenvironment, as well as mutations in androgen signaling pathway components and further physiological modifications, potentially lead to systemic recurrence of prostate cancer, including the appearance of focal tumor in advanced stage. Optimizing early diagnosis and developing targeted therapy of pancreatic cancer are the key to improving the survival rate of patients. In the episode, we will give you a comprehensive introduction to prostate cancer and its signaling pathways, diagnostic markers, and targeted therapies, as well as Creative Biolabs' antibody-related products and services to help fully understand how important it is to optimize early diagnosis and develop targeted drugs.

An Overview of Pancreatic Cancer

Pancreatic cancer is one of the malignant tumors with strong invasiveness, high degree of deterioration, and low surgical resection rate in the digestive system. Optimizing early diagnosis and developing targeted therapy of pancreatic cancer are the key to improving the survival rate of patients. In the episode, we will give you a comprehensive introduction to pancreatic cancer and its signaling pathways, diagnostic markers, and targeted therapies, as well as Creative Biolabs' antibody-related products and services to help fully understand how important it is to optimize early diagnosis and develop targeted drugs.

An Overview of Endometrial Cancer

Endometrial cancer is the most common female genital cancer in the developed world. In the United States of America, an estimated 2.8% of women will be diagnosed with this malignancy at some point in their lifetime. Therefore, in order to improve the benefit of screening and the survival rate of patients, it is very important to establish a system of early diagnosis and targeted therapy for endometrial cancer. In the episode, we will give you a comprehensive introduction to endometrial cancer and its signaling pathways, diagnostic markers, and targeted therapies, as well as Creative Biolabs' antibody-related products and services.